United Kingdom & Prologis

United Kingdom: The UK sees another major company acquired by a US firm, reflecting a trend of foreign takeovers. The deal may have implications for UK capital markets and corporate governance.

Prologis: Prologis is the acquirer, expanding its European operations and gaining Segro's development pipeline. The deal strengthens its global scale but involves significant cash and stock outlay.

United Kingdom: The UK benefits from GSK's investment in its life sciences ecosystem, reinforcing its attractiveness for R&D.

Prologis: Prologis is developing the new R&D centre for GSK, benefiting from the construction contract.

Prologis: Prologis, Inc. (Prologis) is a publicly traded company that will hold a 30% interest in the new joint venture, Prologis Logistics Investment Venture Europepe (PLIVE), and will serve as the operating partner, providing asset management and development expertise. This expands its presence in Europepe.